US Stock MarketDetailed Quotes

Voyager Therapeutics (VYGR)

Watchlist
  • 4.170
  • +0.270+6.92%
Close May 6 15:59 ET
  • 4.180
  • +0.010+0.24%
Post 20:01 ET
251.94MMarket Cap-2.04P/E (TTM)

Voyager Therapeutics (VYGR) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Total revenue
-49.53%40.37M
144.28%15.34M
-45.73%13.37M
-82.42%5.2M
-66.83%6.47M
-68.00%80M
-93.03%6.28M
433.79%24.63M
509.48%29.58M
-87.03%19.52M
Operating revenue
-49.53%40.37M
144.28%15.34M
-45.73%13.37M
-82.42%5.2M
-66.83%6.47M
-68.00%80M
-93.03%6.28M
433.79%24.63M
509.48%29.58M
-87.03%19.52M
Cost of revenue
Gross profit
Operating expense
5.47%172.22M
1.55%45.27M
14.45%43.96M
-6.23%41.83M
15.31%41.17M
27.57%163.29M
23.83%44.58M
12.57%38.41M
47.31%44.6M
29.36%35.7M
Selling and administrative expenses
4.52%37.54M
3.58%9.32M
-0.92%8.09M
3.39%10.5M
12.00%9.64M
0.27%35.92M
-12.19%8.99M
-1.09%8.17M
22.39%10.15M
-4.66%8.61M
-General and administrative expense
4.52%37.54M
3.58%9.32M
-0.92%8.09M
3.39%10.5M
12.00%9.64M
0.27%35.92M
-12.19%8.99M
-1.09%8.17M
22.39%10.15M
-4.66%8.61M
Research and development costs
5.74%134.67M
1.04%35.95M
18.60%35.87M
-9.06%31.33M
16.37%31.53M
38.19%127.37M
38.15%35.58M
16.93%30.24M
56.71%34.45M
45.91%27.09M
Operating profit
-58.30%-131.84M
21.85%-29.93M
-122.02%-30.59M
-143.76%-36.63M
-114.38%-34.69M
-168.26%-83.29M
-170.84%-38.3M
53.30%-13.78M
40.91%-15.03M
-113.17%-16.18M
Net non-operating interest income expense
-42.07%10.62M
-47.15%2.11M
-47.91%2.39M
-42.08%2.83M
-32.38%3.29M
56.37%18.33M
26.63%3.99M
33.54%4.58M
49.30%4.89M
161.11%4.87M
Non-operating interest income
----
----
-47.91%2.39M
-42.08%2.83M
-32.38%3.29M
----
----
33.54%4.58M
49.30%4.89M
161.11%4.87M
Total other finance cost
42.07%-10.62M
----
----
----
----
-56.37%-18.33M
----
----
----
----
Other net income (expense)
165.11%1.65M
0.50%404K
100.00%400K
2,035.00%427K
418K
20,633.33%622K
402K
200K
566.67%20K
Other non- operating income (expenses)
165.11%1.65M
0.50%404K
100.00%400K
2,035.00%427K
--418K
20,633.33%622K
--402K
--200K
566.67%20K
----
Income before tax
-85.86%-119.58M
19.13%-27.42M
-208.95%-27.81M
-229.81%-33.37M
-173.81%-30.98M
-148.11%-64.34M
-159.25%-33.9M
65.48%-9M
54.32%-10.12M
-109.07%-11.32M
Income tax
-78.35%144K
-98.46%9K
93.02%83K
-37.50%15K
164.29%37K
-52.77%665K
-28.95%584K
124.29%43K
-59.32%24K
-98.01%14K
Net income
-84.18%-119.72M
20.47%-27.43M
-208.40%-27.89M
-229.18%-33.38M
-173.80%-31.02M
-149.12%-65M
-161.15%-34.49M
65.08%-9.04M
54.34%-10.14M
-109.13%-11.33M
Net income continuous Operations
-84.18%-119.72M
20.47%-27.43M
-208.40%-27.89M
-229.18%-33.38M
-173.80%-31.02M
-149.12%-65M
-161.15%-34.49M
65.08%-9.04M
54.34%-10.14M
-109.13%-11.33M
Minority interest income
Net income attributable to the parent company
-84.18%-119.72M
20.47%-27.43M
-208.40%-27.89M
-229.18%-33.38M
-173.80%-31.02M
-149.12%-65M
-161.15%-34.49M
65.08%-9.04M
54.34%-10.14M
-109.13%-11.33M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-84.18%-119.72M
20.47%-27.43M
-208.40%-27.89M
-229.18%-33.38M
-173.80%-31.02M
-149.12%-65M
-161.15%-34.49M
65.08%-9.04M
54.34%-10.14M
-109.13%-11.33M
Basic earnings per share
-80.53%-2.04
20.34%-0.47
-193.75%-0.47
-216.67%-0.57
-165.00%-0.53
-136.69%-1.13
-147.97%-0.59
72.88%-0.16
64.71%-0.18
-106.56%-0.2
Diluted earnings per share
-80.53%-2.04
20.34%-0.47
-193.75%-0.47
-216.67%-0.57
-165.00%-0.53
-138.05%-1.13
-149.58%-0.59
72.88%-0.16
64.71%-0.18
-106.80%-0.2
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Total revenue -49.53%40.37M144.28%15.34M-45.73%13.37M-82.42%5.2M-66.83%6.47M-68.00%80M-93.03%6.28M433.79%24.63M509.48%29.58M-87.03%19.52M
Operating revenue -49.53%40.37M144.28%15.34M-45.73%13.37M-82.42%5.2M-66.83%6.47M-68.00%80M-93.03%6.28M433.79%24.63M509.48%29.58M-87.03%19.52M
Cost of revenue
Gross profit
Operating expense 5.47%172.22M1.55%45.27M14.45%43.96M-6.23%41.83M15.31%41.17M27.57%163.29M23.83%44.58M12.57%38.41M47.31%44.6M29.36%35.7M
Selling and administrative expenses 4.52%37.54M3.58%9.32M-0.92%8.09M3.39%10.5M12.00%9.64M0.27%35.92M-12.19%8.99M-1.09%8.17M22.39%10.15M-4.66%8.61M
-General and administrative expense 4.52%37.54M3.58%9.32M-0.92%8.09M3.39%10.5M12.00%9.64M0.27%35.92M-12.19%8.99M-1.09%8.17M22.39%10.15M-4.66%8.61M
Research and development costs 5.74%134.67M1.04%35.95M18.60%35.87M-9.06%31.33M16.37%31.53M38.19%127.37M38.15%35.58M16.93%30.24M56.71%34.45M45.91%27.09M
Operating profit -58.30%-131.84M21.85%-29.93M-122.02%-30.59M-143.76%-36.63M-114.38%-34.69M-168.26%-83.29M-170.84%-38.3M53.30%-13.78M40.91%-15.03M-113.17%-16.18M
Net non-operating interest income expense -42.07%10.62M-47.15%2.11M-47.91%2.39M-42.08%2.83M-32.38%3.29M56.37%18.33M26.63%3.99M33.54%4.58M49.30%4.89M161.11%4.87M
Non-operating interest income ---------47.91%2.39M-42.08%2.83M-32.38%3.29M--------33.54%4.58M49.30%4.89M161.11%4.87M
Total other finance cost 42.07%-10.62M-----------------56.37%-18.33M----------------
Other net income (expense) 165.11%1.65M0.50%404K100.00%400K2,035.00%427K418K20,633.33%622K402K200K566.67%20K
Other non- operating income (expenses) 165.11%1.65M0.50%404K100.00%400K2,035.00%427K--418K20,633.33%622K--402K--200K566.67%20K----
Income before tax -85.86%-119.58M19.13%-27.42M-208.95%-27.81M-229.81%-33.37M-173.81%-30.98M-148.11%-64.34M-159.25%-33.9M65.48%-9M54.32%-10.12M-109.07%-11.32M
Income tax -78.35%144K-98.46%9K93.02%83K-37.50%15K164.29%37K-52.77%665K-28.95%584K124.29%43K-59.32%24K-98.01%14K
Net income -84.18%-119.72M20.47%-27.43M-208.40%-27.89M-229.18%-33.38M-173.80%-31.02M-149.12%-65M-161.15%-34.49M65.08%-9.04M54.34%-10.14M-109.13%-11.33M
Net income continuous Operations -84.18%-119.72M20.47%-27.43M-208.40%-27.89M-229.18%-33.38M-173.80%-31.02M-149.12%-65M-161.15%-34.49M65.08%-9.04M54.34%-10.14M-109.13%-11.33M
Minority interest income
Net income attributable to the parent company -84.18%-119.72M20.47%-27.43M-208.40%-27.89M-229.18%-33.38M-173.80%-31.02M-149.12%-65M-161.15%-34.49M65.08%-9.04M54.34%-10.14M-109.13%-11.33M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -84.18%-119.72M20.47%-27.43M-208.40%-27.89M-229.18%-33.38M-173.80%-31.02M-149.12%-65M-161.15%-34.49M65.08%-9.04M54.34%-10.14M-109.13%-11.33M
Basic earnings per share -80.53%-2.0420.34%-0.47-193.75%-0.47-216.67%-0.57-165.00%-0.53-136.69%-1.13-147.97%-0.5972.88%-0.1664.71%-0.18-106.56%-0.2
Diluted earnings per share -80.53%-2.0420.34%-0.47-193.75%-0.47-216.67%-0.57-165.00%-0.53-138.05%-1.13-149.58%-0.5972.88%-0.1664.71%-0.18-106.80%-0.2
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------
Market Insights
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
The negotiations between the US and Iran have entered a critical window amid external expectations and various parties' maneuvering, with th Show More